STAT

MAY 9, 2025

WASHINGTON — U.S. regulators have approved the first  cervical cancer  testing kit that allows women to collect their own sample at home before shipping it to a laboratory, according to a medical device company. Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to collect vaginal samples that can detect the HPV virus that causes cervical cancer.

330

330

pharmaphorum

MAY 9, 2025

GSK reveals the data behind its linerixibat for itching associated with autoimmune liver disease PBC as it anticipates first approvals for the drug.

70

70

STAT

MAY 9, 2025

Less than two years ago, I completed a three-year emergency medicine residency and, after passing written and oral board exams, became a board-certified emergency physician. Now, the Accreditation Council for Graduate Medical Education is claiming that three years of personal and financial sacrifice are not enough.  The ACGME reviews each specialty’s program requirements every 10 years, and it recently released their proposed updates for emergency medicine.

Hospitals 280

Hospitals 280

Pharma Marketing Network

MAY 9, 2025

What does it take to bring a life-saving therapy to market and ensure patients can actually access it? Behind every successful drug launch lies a labyrinth of negotiations, pricing models, and payer strategies. Understanding the pharmaceutical market access process is crucialnot only for commercialization teams but for marketers and strategists looking to position their brands competitively.

Packaging 52

Packaging Documentation Communication 52

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

STAT

MAY 9, 2025

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

199

199

STAT

MAY 9, 2025

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. I had planned to make this box about a recent study that confirmed some birds form friendships. But as a lapsed Catholic who spends too much of her time watching college basketball (shout-out Xavier University), I am *thrilled* that we’re getting a pope who seemingly knows ball.

218

218

pharmaphorum

MAY 9, 2025

Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals proved optimistic.

66

66

STAT

MAY 9, 2025

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Today, we talk about the FDA’s new artificial intelligence effort in the wake of mass layoffs, see AI darling Insitro cut staff, and more.

Drug Pricing 176

Drug Pricing Drug Development 176

pharmaphorum

MAY 9, 2025

Biotech pressures exposed as big job losses are announced at Vor Bio, IGM Biosciences, Rallybio, Insitro, and Korro Bio.

59

59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

European Pharmaceutical Review

MAY 9, 2025

A next-generation CAR T cell therapy has shown promise for treatment-resistant B-cell lymphoma, new research shows. Results from the Phase I clinical trial found that the treatment reduced cancer in 81 percent of patients, and enabled complete remission in 52 percent of patients. These findings are notable, because over half of lymphoma patients given currently available CAR T therapies, a form of personalised immunotherapy, do not experience long-term remission, the researchers explained.

52

52

pharmaphorum

MAY 9, 2025

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in early bladder cancer

59

59

PharmExec

MAY 9, 2025

Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how regulatory, patent, and reimbursement challenges are slowing venture investment in GLP-1 and psychedelic addiction therapies.

52

52

pharmaphorum

MAY 9, 2025

With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead.

52

52

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Pharmaceutical Commerce

MAY 9, 2025

In the second part of his Pharma Commerce video interview, Michael Rowe, Two Labs senior director of DSCSA/serialization compliance services, comments on stakeholders overall preparedness for complying with the latest enforcement deadlines.

52

52

PharmExec

MAY 9, 2025

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical response in patients with primary biliary cholangitis.

52

52

Pharmafile

MAY 9, 2025

Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study of GAL-101, a novel therapy aimed to treat serious neurodegenerative eye and brain conditions. The SAD study showed that GAL-101 was well-tolerated and has a strong safety and pharmacokinetic profile. These promising results have allowed […] The post Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases appeared first on Ph

59

59

Pharmacy Times

MAY 9, 2025

The new at-home test aims to increase comfort and screening timeliness through a more accessible method.

56

56

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Pharmaceutical Commerce

MAY 9, 2025

Ways to reimagine pharmas operating model and KPIs for commercial success in an AI-driven future.

59

59

pharmaphorum

MAY 9, 2025

Cost-related nonadherence (CRN) the act of skipping doses, splitting pills, or delaying refills to save money is a major issue among US adults with chronic conditions.

Biosimilars 59

Biosimilars 59

Pharmaceutical Technology

MAY 9, 2025

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.

52

52

Pharmaceutical Commerce

MAY 9, 2025

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

52

52

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmaceutical Technology

MAY 9, 2025

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June 2025.

52

52

Pharma Marketing Network

MAY 9, 2025

Is your healthcare advertising generating the conversions your pharma brand needs? In todays competitive, digitally saturated market, traditional messaging no longer cuts it. Precision targeting, performance insights, and adaptive content are essential to reach both healthcare professionals (HCPs) and patients effectively. Fortunately, the rise of data-driven strategies is helping marketers build more intelligent campaigns that truly convert.

HIPAA 52

HIPAA Communication 52

PharmExec

MAY 9, 2025

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer who have received prior systemic therapy.

52

52

Pharmafile

MAY 9, 2025

Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to accelerate its international growth and service expansion. Founded in London in 2018, PIO was the first SEO agency to serve highly regulated pharma and biotech markets. The company helps clients leverage upcoming technologies, especially artificial […] The post Apiary invests in life sciences SEO pioneer PIO to support global expansion appeared first

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmaceutical Technology

MAY 9, 2025

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from Q1 2024.

Vaccines 52

Vaccines 52

Pharmacy Times

MAY 9, 2025

The most substantial reduction was achieved 2 to 3 years after vaccination with a sustained protective effect lasting up to 8 years

Vaccines 45

Vaccines 45

Pharmaceutical Technology

MAY 9, 2025

Haya Therapeutics has secured $65m in Series A funding to expedite the clinical development of HTX-001 for treating heart failure.

52

52